Japanese (NIKKEI) Biotech Industry Analysis
UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies28
- 7D-0.6%
- 3M11.5%
- 1Y-15.9%
- YTD4.9%
The Biotech is pretty flat in the last 7 days, but CanBas has stood out, gaining 38%. Unfortunately though, the industry is down 16% over the past 12 months. Looking forward, earnings are forecast to grow by 25% annually.
Industry Valuation and Performance
Has the Japanese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Feb 2023 | JP¥946.6b | JP¥186.7b | -JP¥24,854,541,000.00 | 39.7x | -38.1x | 5.1x |
| Sun, 01 Jan 2023 | JP¥930.2b | JP¥186.8b | -JP¥24,722,604,000.00 | 44.6x | -37.6x | 5x |
| Tue, 29 Nov 2022 | JP¥896.3b | JP¥182.1b | -JP¥23,614,604,000.00 | 45.3x | -38x | 4.9x |
| Thu, 27 Oct 2022 | JP¥855.5b | JP¥176.5b | -JP¥24,974,270,000.00 | 48.2x | -34.3x | 4.8x |
| Sat, 24 Sep 2022 | JP¥866.5b | JP¥176.5b | -JP¥24,974,270,000.00 | 44.2x | -34.7x | 4.9x |
| Mon, 22 Aug 2022 | JP¥959.9b | JP¥174.4b | -JP¥21,144,270,000.00 | 21.8x | -45.4x | 5.5x |
| Wed, 20 Jul 2022 | JP¥944.8b | JP¥171.3b | -JP¥16,112,943,000.00 | 21.3x | -58.6x | 5.5x |
| Fri, 17 Jun 2022 | JP¥832.3b | JP¥171.3b | -JP¥16,658,721,000.00 | 21.3x | -50x | 4.9x |
| Sun, 15 May 2022 | JP¥937.9b | JP¥169.1b | -JP¥12,813,215,000.00 | 12x | -73.2x | 5.5x |
| Tue, 12 Apr 2022 | JP¥1.1t | JP¥164.2b | -JP¥13,043,295,000.00 | 15.2x | -82.2x | 6.5x |
| Thu, 10 Mar 2022 | JP¥983.5b | JP¥164.1b | -JP¥9,674,798,000.00 | 14.5x | -101.7x | 6x |
| Sat, 05 Feb 2022 | JP¥1.0t | JP¥163.7b | -JP¥5,383,446,000.00 | 16.1x | -193.5x | 6.4x |
| Mon, 03 Jan 2022 | JP¥1.2t | JP¥163.5b | -JP¥5,447,524,000.00 | 18.4x | -226x | 7.5x |
| Wed, 01 Dec 2021 | JP¥1.3t | JP¥159.5b | -JP¥8,763,358,000.00 | n/a | -145.3x | 8x |
| Fri, 29 Oct 2021 | JP¥1.4t | JP¥147.6b | -JP¥12,269,440,000.00 | 23.4x | -112.2x | 9.3x |
| Sun, 26 Sep 2021 | JP¥1.6t | JP¥147.6b | -JP¥12,269,440,000.00 | 26.1x | -133.3x | 11.1x |
| Tue, 24 Aug 2021 | JP¥1.7t | JP¥148.3b | -JP¥14,096,440,000.00 | 24.7x | -117.2x | 11.1x |
| Wed, 30 Jun 2021 | JP¥1.9t | JP¥139.5b | -JP¥15,500,440,000.00 | 33.2x | -122.9x | 13.7x |
| Sat, 03 Apr 2021 | JP¥1.9t | JP¥122.0b | -JP¥18,475,632,000.00 | 61.1x | -102.2x | 15.5x |
| Tue, 05 Jan 2021 | JP¥1.8t | JP¥103.8b | -JP¥25,953,087,000.00 | 125.6x | -68.8x | 17.2x |
| Fri, 09 Oct 2020 | JP¥1.9t | JP¥84.8b | -JP¥26,206,135,000.00 | 146.4x | -74.2x | 22.9x |
| Thu, 02 Jul 2020 | JP¥1.9t | JP¥78.3b | -JP¥27,486,602,000.00 | 139.8x | -68.1x | 23.9x |
| Sun, 05 Apr 2020 | JP¥1.2t | JP¥78.5b | -JP¥32,046,297,000.00 | 178x | -38.1x | 15.6x |
Price to Earnings Ratio
-51.2x
Current Industry PE
- Investors are pessimistic on the Japanese Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 12.2x is higher than the industry's current PS ratio of 5.1x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Revenues for these companies have grown 34% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | -0.51% | |
| Healthcare | -3.11% | |
| Biotech | -0.64% | |
| Biotech | -0.64% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4575 CanBas | JP¥1.70k | 37.7% +JP¥7.4b | 628.3% | PB20.9x | |
| 4591 Ribomic | JP¥202.00 | 9.2% +JP¥606.8m | 0% | PS92.4x | |
| 2160 GNI Group | JP¥1.23k | 1.0% +JP¥569.8m | 6.5% | PE68.7x | |
| 4884 Kringle Pharma | JP¥732.00 | 5.2% +JP¥193.7m | 13.8% | PS10.1x | |
| 7774 Japan Tissue Engineering | JP¥506.00 | 0.6% +JP¥121.8m | 0% | PS10.5x |